GFM

GF Fund Management Portfolio holdings

AUM $4.97B
This Quarter Return
+21.29%
1 Year Return
3 Year Return
5 Year Return
10 Year Return
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$57.6M
Cap. Flow %
1.16%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Sector Composition

1 Technology 46.23%
2 Consumer Discretionary 14.24%
3 Communication Services 13.85%
4 Consumer Staples 7.1%
5 Healthcare 7.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ABUS icon
526
Arbutus Biopharma
ABUS
$805M
$15K ﹤0.01%
4,852
EOLS icon
527
Evolus
EOLS
$495M
$14.9K ﹤0.01%
1,621
RLAY icon
528
Relay Therapeutics
RLAY
$710M
$14.8K ﹤0.01%
4,286
URGN icon
529
UroGen Pharma
URGN
$873M
$14.8K ﹤0.01%
1,080
CSTL icon
530
Castle Biosciences
CSTL
$683M
$14.6K ﹤0.01%
716
SAGE
531
DELISTED
Sage Therapeutics
SAGE
$14.3K ﹤0.01%
1,566
KALV icon
532
KalVista Pharmaceuticals
KALV
$796M
$14.1K ﹤0.01%
1,247
XNCR icon
533
Xencor
XNCR
$610M
$14.1K ﹤0.01%
1,791
TBPH icon
534
Theravance Biopharma
TBPH
$703M
$13.9K ﹤0.01%
1,258
KROS icon
535
Keros Therapeutics
KROS
$633M
$13.8K ﹤0.01%
1,036
NXRT
536
NexPoint Residential Trust
NXRT
$879M
$13.8K ﹤0.01%
415
-14
-3% -$466
TNGX icon
537
Tango Therapeutics
TNGX
$772M
$13.6K ﹤0.01%
2,665
IOVA icon
538
Iovance Biotherapeutics
IOVA
$901M
$13.4K ﹤0.01%
7,805
PAHC icon
539
Phibro Animal Health
PAHC
$1.6B
$13.3K ﹤0.01%
520
MGTX icon
540
MeiraGTx Holdings
MGTX
$619M
$13K ﹤0.01%
2,001
ARVN icon
541
Arvinas
ARVN
$575M
$12.9K ﹤0.01%
1,759
SAFE
542
Safehold
SAFE
$1.17B
$12.9K ﹤0.01%
832
-39
-4% -$607
TYRA icon
543
Tyra Biosciences
TYRA
$674M
$12.4K ﹤0.01%
1,296
MNMD icon
544
MindMed
MNMD
$702M
$12.2K ﹤0.01%
1,877
TSHA icon
545
Taysha Gene Therapies
TSHA
$917M
$12.1K ﹤0.01%
5,248
ZVRA icon
546
Zevra Therapeutics
ZVRA
$502M
$12K ﹤0.01%
1,367
HCM icon
547
HUTCHMED
HCM
$2.74B
$12K ﹤0.01%
794
SIGA icon
548
SIGA Technologies
SIGA
$603M
$11.9K ﹤0.01%
1,828
PSNL icon
549
Personalis
PSNL
$465M
$11.9K ﹤0.01%
1,809
EVRG icon
550
Evergy
EVRG
$16.5B
$11.8K ﹤0.01%
171
-7,469
-98% -$515K